Tran Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-146,225
Closed -$9.37M 45
2018
Q4
$9.37M Sell
146,225
-45,649
-24% -$3.37M 1.63% 22
2018
Q3
$17.2M Sell
191,874
-5,640
-3% -$498K 2.13% 24
2018
Q2
$15.7M Sell
197,514
-30,548
-13% -$2.54M 2.1% 21
2018
Q1
$20.3M Sell
228,062
-2,934
-1% -$282K 2.64% 21
2017
Q4
$24.1M Buy
230,996
+19,710
+9% +$2.22M 2.29% 21
2017
Q3
$30.8M Sell
211,286
-12,615
-6% -$1.72M 2.76% 17
2017
Q2
$29.1M Sell
223,901
-208,586
-48% -$25.6M 2.62% 20
2017
Q1
$53.8M Sell
432,487
-399,178
-48% -$47.8M 4.32% 9
2016
Q4
$96.3M Sell
831,665
-425,436
-34% -$47.4M 5.89% 3
2016
Q3
$131M Sell
1,257,101
-339,919
-21% -$36.8M 5.37% 8
2016
Q2
$158M Sell
1,597,020
-249,406
-14% -$25.8M 5.34% 6
2016
Q1
$185M Sell
1,846,426
-129,737
-7% -$13.4M 5.6% 10
2015
Q4
$237M Sell
1,976,163
-35,163
-2% -$4.07M 6.34% 5
2015
Q3
$218M Sell
2,011,326
-170,084
-8% -$21.1M 5.31% 6
2015
Q2
$252M Sell
2,181,410
-96,823
-4% -$11.1M 5.94% 6
2015
Q1
$263M Sell
2,278,233
-180,590
-7% -$21.6M 5.69% 4
2014
Q4
$275M Sell
2,458,823
-182,003
-7% -$19.2M 5.26% 4
2014
Q3
$250M Buy
+2,640,826
New +$238M 4.72% 11

Other funds holding CELG

Tran Capital Management's CELG Position: Q1 2019 in Review

Tran Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 146,225 shares — an estimated $9.37M sold.

Tran Capital Management first reported a position in CELG in Q3 2014 and held it in 18 quarters. The position peaked at $275M in Q4 2014. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Tran Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Tran Capital Management sold 146,225 Celgene Corp shares in Q1 2019, an estimated $9.37M.
  • Tran Capital Management first reported a position in Celgene Corp in Q3 2014 and held it in 18 quarters.
  • Tran Capital Management's Celgene Corp position peaked at $275M in Q4 2014.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Tran Capital Management's 13F filing for Q1 2019, filed 15 May 2019.